Drug Type Small molecule drug |
Synonyms Falecalcitriol (JAN/INN), Flocalcitriol, Hexafluorocalcitriol + [18] |
Target |
Action agonists |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Apr 2001), |
Regulation- |
Molecular FormulaC27H38F6O3 |
InChIKeyXPYGGHVSFMUHLH-UUSULHAXSA-N |
CAS Registry83805-11-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01662 | Falecalcitriol | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperparathyroidism | Japan | 04 Apr 2001 | |
Hyperparathyroidism, Secondary | Japan | 01 Apr 2001 | |
Hypoparathyroidism | Japan | 01 Apr 2001 | |
Osteomalacia | Japan | 01 Apr 2001 | |
Rickets | Japan | 01 Apr 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Diseases | Phase 3 | Japan | - | |
Psoriasis | Phase 2 | United States | - | |
Osteoporosis, Postmenopausal | Phase 1 | United States | 08 Dec 1997 | |
Acne Vulgaris | Phase 1 | United States | - | |
Photodamaged skin | Phase 1 | United States | - | |
Well Aging | Discovery | United States | 05 Jun 1997 |